...
首页> 外文期刊>Journal of biomaterials and tissue engineering >pH-Sensitive Eudragit S-100 Coated Chitosan Nanoparticles of 5-Amino Salicylic Acid for Colon Delivery
【24h】

pH-Sensitive Eudragit S-100 Coated Chitosan Nanoparticles of 5-Amino Salicylic Acid for Colon Delivery

机译:pH敏感的Eudragit S-100包覆的5-氨基水杨酸壳聚糖纳米颗粒用于结肠递送。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Site-specific colonic drug delivery system of 5-ASA nanoparticles were prepared and coated with pH sensitive polymer. Chitosan nanoparticles (CTNP) bearing 5-Amino salicylic acid (5-ASA) were prepared, by ionotropic gelation method, nanoparticulate dosage form consisting of a hydrophobic core enteric coated with pH-dependent polymer Eudragit S-100 by solvent evaporation method, for the effective delivery of drug to the colon for treatment of ulcerative colitis. CTNP and Eudragit chitosan nanoparticles (ECTNP) was characterized for shape and surface morphology of nanoparticles by scanning electron microscopy (SEM) appeared to be spherical in shape and the particle size, size distribution and polydispersity index of the drug loaded nanoparticles were assessed by photon correlation spectroscopy using Zeta Sizer mean size was found to be around 159 nm and 501 nm with optimum value of zeta potential was found to be 22 +/- 1.82 and -34.5 +/- 0.8 respectively. The in vitro drug release was investigated using USP dissolution test apparatus in different simulated GIT fluids showed promising release in colonic pH. These data confirmed the CTNP have been developed. The in vitro hennolysis study showed that the complex was non-hemolytic. Thus it can be concluded that the ECTNP may be a promising candidate in colon delivery.
机译:制备了5-ASA纳米颗粒的定点结肠给药系统,并用pH敏感聚合物包被。通过离子胶凝法制备了含5-氨基水杨酸(5-ASA)的壳聚糖纳米粒子(CTNP),该纳米粒子剂型由疏水核心肠溶衣组成,该核心衣壳通过溶剂蒸发法被pH依赖性聚合物Eudragit S-100包覆。有效地将药物输送到结肠以治疗溃疡性结肠炎。 CTNP和Eudragit壳聚糖纳米颗粒(ECTNP)通过扫描电子显微镜(SEM)表征为球形,表征了纳米颗粒的形状和表面形态,并通过光子相关性评估了载药纳米颗粒的粒径,尺寸分布和多分散指数使用Zeta Sizer进行的光谱分析发现平均大小约为159 nm和501 nm,最佳的Zeta电位值分别为22 +/- 1.82和-34.5 +/- 0.8。使用USP溶出度测试仪在不同的模拟GIT液中研究了体外药物释放,结果表明该药物在结肠pH中有希望的释放。这些数据证实了CTNP已经研制成功。体外hennolysis研究表明该复合物是非溶血的。因此可以得出结论,ECTNP可能是结肠输送中有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号